By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Chimerix, Inc. 

2505 Meridian Parkway
Ste 340
Durham  North Carolina  27713  U.S.A.
Phone: 919-806-1074 Fax: 919-806-1146



Company News
Chimerix, Inc. (CMRX) Provides Update On Research and Development Progress; FDA OKs Brincidofovir In Phase 2 For Ebola Virus Disease 10/16/2014 10:40:08 AM
Chimerix, Inc. (CMRX) To Webcast R&D Update On October 15th 10/13/2014 8:09:07 AM
Chimerix, Inc. (CMRX) Slips As Ebola Patient On Brincidofovir Dies 10/10/2014 6:20:47 AM
Chimerix, Inc. (CMRX) Says Brincidofovir Improved Survival In Study Spurred By Boy 10/8/2014 5:53:07 AM
Ebola Patient Gets Chimerix, Inc. (CMRX) Drug, Clinical Trials Planned 10/6/2014 7:33:47 AM
Chimerix, Inc. (CMRX)’s Brincidofovir An Ebola Standout For Traders, Says Analyst 10/2/2014 3:57:37 PM
Data On Chimerix, Inc. (CMRX)'s Brincidofovir Suggests Favorable Resistance Profile In Adenovirus And Cytomegalovirus (CMV) 9/9/2014 7:25:52 AM
Chimerix, Inc. (CMRX) Appoints W. Garrett Nichols, MD, MS As Chief Medical Officer 9/4/2014 10:14:35 AM
Chimerix, Inc. (CMRX)'s Brincidofovir Has In Vitro Activity Against Ebola 9/3/2014 8:00:48 AM
Chimerix, Inc. (CMRX)'s Brincidofovir Selected For Two Oral Presentations Highlighting Resistance Data In CMV And Adenovirus At The 54th Interscience Conference On Antimicrobial Agents And Chemotherapy (ICAAC) 9/3/2014 7:53:57 AM